Publicacions en col·laboració amb investigadors/es de Harvard Medical School (7)

2024

  1. Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemia

    Blood, Vol. 144, Núm. 12, pp. 1257-1270

2023

  1. Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia

    British Journal of Haematology, Vol. 200, Núm. 2, pp. 170-174

2020

  1. NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia

    Scientific Reports, Vol. 10, Núm. 1

  2. Reduced SLIT2 is associated with increased cell proliferation and arsenic trioxide resistance in acute promyelocytic Leukemia

    Cancers, Vol. 12, Núm. 11, pp. 1-16

2014

  1. Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study

    Annals of Hematology, Vol. 93, Núm. 12, pp. 2001-2010

  2. Prognostic impact of KMT2E transcript levels on outcome of patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: An International Consortium on Acute Promyelocytic Leukaemia study

    British Journal of Haematology, Vol. 166, Núm. 4, pp. 540-549

2010

  1. International consensus report on the investigation and management of primary immune thrombocytopenia

    Blood, Vol. 115, Núm. 2, pp. 168-186